Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 6, Number 5, 1 May 2008

Free Content Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction
pp. 720-725(6)
Authors: VAN DER KRABBEN, M. D.; ROSENDAAL, F. R.; VAN DER BOM, J. G.; DOGGEN, C. J. M.

Favourites:
ADD

Free Content Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease
pp. 726-736(11)
Authors: CIRILLO, P.; DE ROSA, S.; PACILEO, M.; GARGIULO, A.; ANGRI, V.; FIORENTINO, I.; PREVETE, N.; PETRILLO, G.; DE PALMA, R.; LEONARDI, A.; DE PAULIS, A.; CHIARIELLO, M.

Favourites:
ADD

Free Content Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population
pp. 737-741(5)
Authors: KAIN, K.; CARTER, A. M.; GRANT, P. J.; SCOTT, E. M.

Favourites:
ADD

Free Content Myocardial infarction and cerebrovascular accident following non‐cardiac surgery: differences in postoperative temporal distribution and risk factors
pp. 742-748(7)
Authors: KIKURA, M.; OIKAWA, F.; YAMAMOTO, K.; IWAMOTO, T.; TANAKA, K. A.; SATO, S.; LANDESBERG, G.

Favourites:
ADD

Free Content Predicting the future: it’s not a SNP
pp. 749-750(2)
Author: KEELING, D.

Favourites:
ADD

Free Content Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis
pp. 751-754(4)
Authors: VAN HYLCKAMA VLIEG, A.; BAGLIN, C. A.; BARE, L. A.; ROSENDAAL, F. R.; BAGLIN, T. P.

Favourites:
ADD

Free Content Health‐related quality of life in a cohort of adult patients with mild hemophilia A
pp. 755-761(7)
Authors: WALSH, M.; MACGREGOR, D.; STUCKLESS, S.; BARRETT, B.; KAWAJA, M.; SCULLY, M.‐F.

Favourites:
ADD

Free Content Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD)
pp. 762-771(10)
Authors: BUDDE, U.; SCHNEPPENHEIM, R.; EIKENBOOM, J.; GOODEVE, A.; WILL, K.; DREWKE, E.; CASTAMAN, G.; RODEGHIERO, F.; FEDERICI, A. B.; BATLLE, J.; PÉREZ, A.; MEYER, D.; MAZURIER, C.; GOUDEMAND, J.; INGERSLEV, J.; HABART, D.; VORLOVA, Z.; HOLMBERG, L.; LETHAGEN, S.; PASI, J.; HILL, F.; PEAKE, I.

Favourites:
ADD

Free Content Prospective multicenter evaluation of the pulmonary embolism rule‐out criteria
pp. 772-780(9)
Authors: KLINE, J. A.; COURTNEY, D. M.; KABRHEL, C.; MOORE, C. L.; SMITHLINE, H. A; PLEWA, M. C.; RICHMAN, P. B.; O'NEIL, B. J.; NORDENHOLZ, K.

Favourites:
ADD

Free Content Venous thromboembolic events and organ‐specific occult cancers: a review and meta‐analysis
pp. 781-788(8)
Authors: IODICE, S.; GANDINI, S.; LÖHR, M.; LOWENFELS, A. B.; MAISONNEUVE, P.

Favourites:
ADD

Free Content A randomized, repeat‐dose, pharmacodynamic and safety study of an antidote‐controlled factor IXa inhibitor
pp. 789-796(8)
Authors: CHAN, M. Y.; RUSCONI, C. P.; ALEXANDER, J. H.; TONKENS, R. M.; HARRINGTON, R. A.; BECKER, R. C.

Favourites:
ADD

Free Content Vitamin K‐induced modification of coagulation phenotype in VKORC1 homozygous deficiency
pp. 797-803(7)
Authors: MARCHETTI, G.; CARUSO, P.; LUNGHI, B.; PINOTTI, M.; LAPECORELLA, M.; NAPOLITANO, M.; CANELLA, A.; MARIANI, G.; BERNARDI, F.

Favourites:
ADD

Free Content Recombinant human factor VIIa and a factor VIIa‐analogue reduces heparin and low molecular weight heparin (LMWH)‐induced bleeding in rats
pp. 804-811(8)
Authors: LAURITZEN, B.; HEDNER, U.; JOHANSEN, P. B.; TRANHOLM, M.; EZBAN, M.

Favourites:
ADD

Free Content Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
pp. 812-819(8)
Authors: PALUMBO, J. S.; BARNEY, K. A.; BLEVINS, E. A.; SHAW, M. A.; MISHRA, A.; FLICK, M. J.; KOMBRINCK, K. W.; TALMAGE, K. E.; SOURI, M.; ICHINOSE, A.; DEGEN, J. L.

Favourites:
ADD

Free Content Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies
pp. 820-829(10)
Authors: WONG, P. C.; CRAIN, E. J.; XIN, B.; WEXLER, R. R.; LAM, P. Y. S.; PINTO, D. J.; LUETTGEN, J. M.; KNABB, R. M.

Favourites:
ADD
Favourites:
ADD

Free Content Thrombostatin FM compounds: direct thrombin inhibitors – mechanism of action in vitro and in vivo
pp. 837-845(9)
Authors: NIEMAN, M. T.; BURKE, F.; WARNOCK, M.; ZHOU, Y.; SWEIGART, J.; CHEN, A.; RICKETTS, D.; LUCCHESI, B. R.; CHEN, Z.; DI CERA, E.; HILFINGER, J.; KIM, J. S.; MOSBERG, H. I.; SCHMAIER, A. H.

Favourites:
ADD
Favourites:
ADD

Free Content Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity
pp. 848-855(8)
Authors: WALKER, J. B.; BINETTE, T. M.; MACKOVA, M.; LAMBKIN, G. R.; MITCHELL, L.; BAJZAR, L.

Favourites:
ADD
Favourites:
ADD

Free Content Circulating endothelial cells: from bench to clinical practice
pp. 865-868(4)
Authors: SHANTSILA, E.; BLANN, A. D.; LIP, G. Y. H.

Favourites:
ADD

Free Content CD146‐based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells
pp. 869-876(8)
Authors: WIDEMANN, A.; SABATIER, F.; ARNAUD, L.; BONELLO, L.; AL‐MASSARANI, G.; PAGANELLI, F.; PONCELET, P.; DIGNAT‐GEORGE, F.

Favourites:
ADD

Free Content SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells
pp. 877-884(8)
Authors: TARDOS, J. G.; EISENREICH, A.; DEIKUS, G.; BECHHOFER, D. H.; CHANDRADAS, S.; ZAFAR, U.; RAUCH, U.; BOGDANOV, V. Y.

Favourites:
ADD

Free Content A case of non‐resolving hemophilia B Leyden in a 42‐year‐old male (F9 promoter + 13 A>G)
pp. 885-886(2)
Authors: JAMES, P. D.; STAKIW, J.; LEGGO, J.; WALKER, I.; LILLICRAP, D.

Favourites:
ADD

Free Content Prevalence of type 2b ‘Malmö/New York’ von Willebrand disease in Italy: the role of von Willebrand factor gene conversion
pp. 887-890(4)
Authors: BARONCIANI, L.; FEDERICI, A. B.; CASTAMAN, G.; PUNZO, M.; MANNUCCI, P. M.

Favourites:
ADD

Free Content Long elimination half‐life of idraparinux may explain major bleeding and recurrent events of patients from the van Gogh trials
pp. 890-892(3)
Authors: HARENBERG, J.; VUKOJEVIC, Y.; MIKUS, G.; JOERG, I.; WEISS, C.

Favourites:
ADD

Free Content Circulating anticoagulant glycosaminoglycans in mucopolysaccharidosis type I
pp. 893-895(3)
Authors: TOLAR, J.; ORCHARD, P. J.; KEY, N. S.; BLAZAR, B. R.

Favourites:
ADD

Free Content Join ISTH
pp. 896-896(1)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more